Applied Health Economics and Health Policy

Papers
(The TQCC of Applied Health Economics and Health Policy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Cost-Effectiveness and Value of Information Analyses of Caplacizumab for the Treatment of Thrombotic Thrombocytopenic Purpura in Brazil192
Cost-Effectiveness of a Universal School-Based Mental Health Prevention Program: An Economic Modeling Study in a Limited Income Context100
Therapy, Pills and Unmet Needs for Financial Reasons: Socioeconomic Inequalities and Inequities in Access to Mental Health Care in Spain 2014–202051
Cost-Effectiveness Analysis of Evolocumab or Inclisiran in Combination with Statins Versus Statin Monotherapy Among Patients with ASCVD in China42
Partnerships in Public Health Economics: Reflective Lessons from UK Obesity Research38
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual Framework33
Improving Consumer Engagement in Health Technology Assessment and Decision Making: Lessons from ‘Values in Science’32
Assessing the Direct Impact of Death on Discrete Choice Experiment Utilities29
Cost-Effectiveness of Perinatal Depression Screening: A Scoping Review28
Cost-Effective and Sustainable Drug Use in Hospitals: A Systematic and Practice-Based Approach28
Which Factors are Holding up the Integration of the Environmental Impact of Health Technologies in Health Technology Assessment? Insights from a Multi-Stakeholder Interview Study26
Exploratory Approach to Incorporating Carbon Footprint in Health Technology Assessment (HTA) Modelling: Cost-Effectiveness Analysis of Health Interventions in the United Kingdom25
Applications of Behavioral Economics to Pharmaceutical Policymaking: A Scoping Review with Implications for Best-Value Biological Medicines25
A Guideline-Implementation Intervention to Improve the Management of Low Back Pain in Primary Care: A Difference-in-Difference-in-Differences Analysis22
Economic Evaluation of Evusheld for Preexposure Prevention of COVID-19 in High-Risk Populations: Early Evidence from Thailand18
Selection and Prioritization of Medical Devices for HTA Evaluation: A Systematic Review of Existing Approaches18
Financing Comprehensive Immunization Services in Lao PDR: A Fiscal Space Analysis From a Public Policy Perspective17
The Economics of Antibiotic Resistance: A Systematic Review and Meta-analysis Based on Global Research17
Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions17
10 Years of AMNOG: What is the Willingness-to-Pay for Pharmaceuticals in Germany?16
Economic Evaluation Evidence for Resource-Allocation Decision Making: Bridging the Gap for Local Decision Makers Using English Case Studies16
Local Level Economic Evaluation: What is it? What is its Value? Is it Sustainable?16
Correction to: Cost Effectiveness of Allogeneic Umbilical Cord Blood-Derived Mesenchymal Stem Cells in Patients with Knee Osteoarthritis15
Acknowledgement to Reviewers15
The Economic Cost of Rising Non-communicable Diseases in India: A Systematic Literature Review of Methods and Estimates15
A Systematic Review of the World’s Largest Government Sponsored Health Insurance Scheme for 500 Million Beneficiaries in India: Pradhan Mantri Jan Arogya Yojana14
Including Pharmaceuticals in Bundled Payments14
Politicised Changes to the NICE Threshold Risk Making Cost-Effectiveness Analysis Performative, Not Informative14
How is Value Defined in Molecular Testing in Cancer? A Scoping Review14
A Cost–Utility Analysis of Surgical Site Infection Prevention: Broadening the Scope14
Economic Effects of Fixed-Dose Versus Loose-Dose Combination Therapy for Type 2 Diabetes Patients13
Estimating the Health Effects of Expansions in Health Expenditure in Indonesia: A Dynamic Panel Data Approach13
Quality-Adjusted Life Expectancy and Cost-Effectiveness Thresholds in Three High-Income Regions in Asia13
Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?13
The Impact of Unrelated Future Medical Costs on Economic Evaluation Outcomes for Different Models of Diabetes13
How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts13
Development of a Health Technology Assessment Quality Appraisal Checklist (HTA-QAC) for India13
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon12
Social Costs of Smoking in the Czech Republic12
Economic Evaluation of Bruton’s Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa12
Contextual Factors that Influence Antibiotic Prescribing: A Discrete Choice Experiment of GP Registrars12
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia11
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy11
A Systematic Review of Cost-Effectiveness Analyses of Colorectal Cancer Screening in Europe: Have Studies Included Optimal Screening Intensities?11
Correction to: Different Frameworks, Similar Results? Head-to-Head Comparison of the Generic Preference-Based Health-Outcome Measures CS-Base and EQ-5D-5L11
Measures of Performance and Clinical Superiority Thresholds for ‘Test-and-treat’ Predictive Biomarkers11
Young People’s Preferences for Web-Based Mental Health Interventions for Managing Anxiety and Depression: A Discrete Choice Experiment10
Use of Cost-Effectiveness Thresholds in Healthcare Public Policy: Progress and Challenges10
Sedaconda ACD-S for Sedation with Volatile Anaesthetics in Intensive Care: A NICE Medical Technologies Guidance10
Guiding Health Resource Allocation: Using Population Net Health Benefit to Align Disease Burden with Cost Effectiveness for Informed Decision Making10
Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland10
Machine Learning-Assisted Health Economics and Policy Reviews: A Comparative Assessment10
Trump’s Drug Pricing Order and the Domestic Economic Trade-Off10
Is Economic Evaluation and Care Commissioning Focused on Achieving the Same Outcomes? Resource-Allocation Considerations and Challenges Using England as a Case Study10
Cost-Effectiveness of Anti-retroviral Adherence Interventions for People Living with HIV: A Systematic Review of Decision Analytical Models10
Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–204010
Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older9
Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians9
The Health Economics of Genomic Technologies: A Growing Evidence Base on Value9
Measurement of Catastrophic Health Expenditure in India: A Systematic Review and Meta-Analysis9
The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework9
Mechanisms Considering Public Investment in Pricing and Reimbursement Decisions of Medicines and Other Health Technologies: A Scoping Review9
Comparing Preferences for Disease Profiles: A Discrete Choice Experiment from a US Societal Perspective8
Analysing the Efficiency of Health Systems: A Systematic Review of the Literature8
Headroom Analysis for Early Economic Evaluation: A Systematic Review8
Productivity Loss and Indirect Costs for Patients Newly Diagnosed with Early- versus Late-Stage Cancer in the USA: A Large-Scale Observational Research Study8
A Head-On Comparison of EQ-VT- and Crosswalk-Based EQ-5D-5L Value Sets8
A Systematic Review of Economic Evaluations on Interventions Targeting Insomnia or Hypersomnia8
The Limitations and Potentials of Evaluating Economic Aspects of Community-Based Health Promotion: A Critical Review8
Discrete Event Simulation in R using the ‘Simmer’ Package for Health Economic Modelling: A Tutorial and Illustration in Colon Cancer7
A Systematic Review of Health Economic Evaluations and Budget Impact Analyses to Inform Healthcare Decision-Making in Central America7
EQ-5D-5L Population Norms for Italy7
Using Genomic Heterogeneity to Inform Therapeutic Decisions for Metastatic Colorectal Cancer: An Application of the Value of Heterogeneity Framework7
Estimating a Drug’s Price After Loss of Exclusivity as a Function of Its Cost of Goods Sold7
Ensuring Epidemiological Consistency in Risk-Stratified Cancer Screening Models: A Novel Approach Based on Flemish Breast Cancer Screening7
Estimated Carbon Savings from Changing Surgical Trends in Primary Elective Total Hip Arthroplasty in England: A Retrospective Observational Study7
Costs and Budget Impact of a Health System Strengthening Intervention for Hypertension and Cardiovascular Disease Care in Ghana6
Use of Decision-Analytic Modelling to Assess the Cost-Effectiveness of Diagnostic Imaging of the Spine, Shoulder, and Knee: A Scoping Review6
Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends6
New Horizons? Assessing General Public Preferences for a Wellbeing Economy in the Post-COVID-19 World6
Cost-Utility Analysis of TNF-α Inhibitors, B Cell Inhibitors, and JAK Inhibitors Versus csDMARDs for Rheumatoid Arthritis Treatment6
Genetic Test Utilization and Cost among Families of Children Evaluated for Genetic Conditions: An Analysis of USA Commercial Claims Data6
Exploring Consumer Preferences for Cannabis Vaping Products to Support Public Health Policy: A Discrete Choice Experiment6
Health Reform in Aotearoa New Zealand: Insights on Health Equity Challenges One Year On6
Model-Based Economic Evaluations of Interventions for Dementia: An Updated Systematic Review and Quality Assessment6
The Role of Price Variation in Economic Analyses for Cancer Screenings: A Rapid Review6
Cost-Effectiveness and Value of Information Analysis of an Ambient Intelligent Geriatric Management (AmbIGeM) System Compared to Usual Care to Prevent Falls in Older People in Hospitals6
Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)6
Modelled Distributional Cost-Effectiveness Analysis of Childhood Obesity Interventions: A Demonstration6
The Impact of Value-Based Payment Models for Networks of Care and Transmural Care: A Systematic Literature Review6
Preferences for Digital Mental Health Services in Urban China: A Discrete Choice Experiment6
Structured Expert Elicitation to Inform Long-Term Survival Extrapolations in Advanced Renal Cell Carcinoma6
Utilising Health Technology Assessment to Develop Managed Access Protocols to Facilitate Drug Reimbursement in Ireland6
Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe6
Correction: Economic Evaluations of Robotic-Assisted Surgery: Methods, Challenges and Opportunities6
0.13012385368347